Lycopene Embedded into Cocoa Butter Micelles of Dark Chocolate Causes Dose-dependent Decrease in Serum Lipids of Hypercholesterolemic Volunteers
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 13, Issue 11
Abstract
Aim: To investigate if different amounts of lycopene embedded into cocoa butter micelles of dark chocolate affect serum lipid profile of hypercholesterolemia patients. Study Design: 32 clinically healthy volunteers with borderline hyperlipidemia were enrolled in a 4 week dietary trial. The study participants ingested daily one 10 g bar of L-tug dark chocolate (DC) which contained 0, 2, 3.5 or 7 mg of lycopene with no other restrictions/modifications to their habitual diet. Serum specimens were collected at the outset and after the second and fourth weeks of the trial. The study was conducted at the Saratov’s Institute of Cardiology (Russian Federation) using dark chocolate specimens provided by Lycotec Ltd (Cambridge, UK) during January-March 2013 under approved and registered protocol. Results: It was found that even the lowest concentration of lycopene tested (2 mg) caused a statistically significant (p<0.05) decline in the total cholesterol value at the end of the trial [from a median of 230.5 mg/dl (95% CI: 243.6, 204.8) to 210.5 mg/dl (95%CI: 221.7, 200.1)]. Consumption of higher amounts of lycopene embedded into L-tug DC caused an even more significant step-wise decline in total cholesterol values which were observable from the second week of the trial. There was a corresponding decline in LDL-cholesterol and triglyceride values. Consumption of L-tug DC with the highest amount of lycopene (7 mg) caused a small but statistically significant (P<0.05) increase in HDL values at the end of the interventional period [from a median of 40 mg/dl (95% CI: 43.65, 39) to 42 (95%CI: 43.65, 40.35)]. Conclusion: Lycopene-containing L-tug DC can be used for dietary management of abnormalities of lipid homeostasis in mild hyperlipidemia.
Authors and Affiliations
Ivan M. Petyaev, Pavel Y. Dovgalevsky, Natalia E. Chalyk, Victor A. Klochkov, Nigel H. Kyle
Keywords
Related Articles
- EP ID EP340753
- DOI 10.9734/BJMMR/2016/23623
- Views 73
- Downloads 0
Clinical Features and Prognostic Significance of Endobronchial Sarcoidosis
Aims: Endobronchial involvement may occur in patients with sarcoidosis. Although the prevalence of bronchial abnormalities is high, there are no firm data establishing the clinical features and prognosis of sarcoidosis i...
Cultural Myths and Perceptions Regarding the Usage of Nasogastric Tube amongst Adult Maxillofacial Surgery Patients of a Tertiary Health Centre in Nigeria
Background: Nasogastric tubes (NGT) are used in the clinical setting for the management of patients who require nutritional support amongst others. Knowledge of the perceptions and Myths about NGT use would help address...
Insufficiency of Currently used Dental Indices in Epidemiology
The World Health Organization (WHO) classifies oral diseases in two different ways: officially dental caries (K02) and gingivitis as well periodontal diseases (K.05) are diseases in the digestive system. In epidemiologic...
Endodontic Management of C-shaped Canals in Mandibular Second Molars
Aim: C shaped canal, a common root canal variation in mandibular molars mandates thorough identification and management, when present. Of the several known configurations of C-shaped canals, one often seen is the root ca...
A Novel Approach for Innovative Pharmaceutical, Nutraceutical and Biocosmeceutical Products: Different Types of Combination Products and Co-activation of Natural Synergistically Acting Target-Receptors (CanSATs)
Traditionally, the main model of the pharmaceutical industry for developing new drugs has been based on monotherapies, new molecular entities (NMEs), and their underlying one-target-one-disease dogma. It is no surprise t...